ACUMEN PHARMACEUTICALS INC shareholders Q2 2024

ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 83 filers reported holding ACUMEN PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.

ACUMEN PHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Sands Capital Ventures, LLC 3,417,075$8,269,3222.77%
RA Capital Management 14,932,063$36,135,5920.48%
Knollwood Investment Advisory, LLC 1,628,510$3,940,9940.44%
Rock Springs Capital Management LP 2,300,059$5,566,1430.17%
Ikarian Capital, LLC 266,435$644,7740.11%
CATALYST FINANCIAL PARTNERS LLC 89,699$217,0720.05%
OXFORD ASSET MANAGEMENT LLP 15,304$37,0360.04%
Laurion Capital Management LP 1,178,338$2,851,5780.03%
Intrepid Financial Planning Group LLC 30,150$72,9630.03%
Murchinson Ltd. 56,250$136,1250.02%
Alyeska Investment Group, L.P. 939,603$2,273,8390.01%
Hudson Bay Capital Management LP 670,000$1,621,4000.01%
PRELUDE CAPITAL MANAGEMENT, LLC 46,410$112,3120.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 148,400$359,1280.01%
BOOTHBAY FUND MANAGEMENT, LLC 85,458$206,8080.01%
Marathon Trading Investment Management LLC 26,298$63,6410.01%
Pathstone Holdings, LLC 480,223$1,162,1400.01%
Pinnacle Wealth Management Advisory Group, LLC 18,020$43,6080.01%
Virtu Financial LLC 24,402$590.00%
Gladius Capital Management LP 10,939$26,4730.00%
External links

This page lists ACUMEN PHARMACEUTICALS INC's shareholders in Q2 2024. To view ACUMEN PHARMACEUTICALS INC's shareholder history, click here.